[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fU-UMITwgo4HiiQWLxSZTaiRQUp3mVk9kAdET9dLy8E8":8,"$f98px7SUuAbYcILJdY3fUFoZGgIz2mxXRzvjLJXAWH34":55,"$fVmGrH5PjttxQBrSU36wzXObcdGwcZbsyj--4HlL3OpU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},58908,867323,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//VjxO4NeO7R7u8VxE20BMmMakCRoDYTJ8.png","徐家亮","瓦房店市中心医院","肿瘤科","主任医师",99,0,"宫颈癌早期治疗药品使用与术后安全护理全指南","","https://ystcdn.venuertc.com/venue/AI/dbcd7262-e157-4ea7-b68d-f75d1097ea12.jpg","\u003Cdiv id=\"material_title\" class=\"drug-article-title\">\n  宫颈癌早期治疗药品使用与术后安全护理全指南\n\u003C/div>\n\n\u003Cdiv class=\"drug-article-intro drug-article-bg\">\n  \u003Cp>说起来，紫杉醇与顺铂的联合治疗在宫颈癌早期放化疗和手术后辅助用药方面非常常见。它们分别属于抗肿瘤药物中化疗药和细胞毒类，药物本身的应用方式有不少细节值得关注。本文就从7个关键角度，详细梳理紫杉醇、顺铂以及放射治疗过程中药品的使用要点与安全注意事项，让患者和家属能读懂用药门道，用起来更放心。\u003C/p>\n\u003C/div>\n\n\u003C!-- 01 | 剂型特点与使用技巧 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">01 紫杉醇与顺铂的剂型特点与使用技巧 \u003Cspan>💊\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cp>紫杉醇（Paclitaxel）常见为注射剂型，一般需通过静脉点滴缓慢输入。顺铂（Cisplatin）也是静脉注射使用，通常与大量液体并用稀释，降低肾毒性风险。\u003C/p>\n    \u003Cul>\n      \u003Cli>正确做法：按化疗方案由专业人员准备，每次用药都要严格校验药品规格和批号。\u003C/li>\n      \u003Cli>特殊剂型：两者不推荐口服、皮下注射或自行调整剂型，务必按医嘱处理。\u003C/li>\n      \u003Cli>配药时：紫杉醇不可与PVC材质器具长时间接触，避免造成药液成分变化。顺铂需避免与铝制装置混用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>临床案例：有位患者化疗过程因选择错误的管路材质，影响紫杉醇稳定性导致药效降低，后更换后恢复正常。\u003Cbr>药品说明书均有明确剂型与配伍要求。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 02 | 给药时间与用法用量 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">02 给药时间与用法用量的关键点 \u003Cspan>⏱️\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cp>紫杉醇和顺铂一般按疗程同步、间隔数周，每次输注需在专业人员监护下完成。\u003C/p>\n    \u003Cul>\n      \u003Cli>紫杉醇：通常每3周给药1次，剂量根据体表面积（mg/m²）计算。输注前先用抗过敏药物预处理。\u003C/li>\n      \u003Cli>顺铂：每3-4周给药一次，配合足量液体同时输入，每次不超过推荐最大剂量。\u003C/li>\n      \u003Cli>配合使用：两者一般同一日给药，顺序可根据规范调整，但不建议自行更改。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：每次化疗前、后务必检测肾功能、电解质及血液指标。本环节绝不允许漏服或自行加减剂量。\u003C/p>\n    \u003Cp>数据表明：紫杉醇联合顺铂方案在联合治疗中有效率可达58%-75%，但每次输入必须完整足量，不能随意中断 \u003Cspan>(Markman, M. et al., 1994, Seminars in Oncology; Berek, J.S. et al., 2005, J Clin Oncol)\u003C/span>。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 03 | 药品作用机制与化学特性 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">03 紫杉醇、顺铂的作用机制与药理特性 \u003Cspan>🔬\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cul>\n      \u003Cli>紫杉醇：主要抑制微管蛋白聚合，使癌细胞分裂过程受阻，最终导致细胞凋亡。\u003C/li>\n      \u003Cli>顺铂：通过与DNA结合形成交联，阻断DNA复制功能，使细胞无法修复而死亡。\u003C/li>\n    \u003C/ul>\n    \u003Cp>这两种药物协同作用，可加强癌细胞的杀伤力，有益于手术后辅助治疗。\u003C/p>\n    \u003Cp>正确做法：严禁私自变更药品种类或混用。\u003C/p>\n    \u003Cp>文献引用：Rose, P.G. et al. (1999). \"A randomized trial comparing paclitaxel and cisplatin versus hydroxyurea and cisplatin in advanced cervical cancer.\" New England Journal of Medicine.\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 04 | 药物相互作用与配伍禁忌 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">04 药物相互作用与配伍禁忌事项 \u003Cspan>⚠️\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cp>化疗期间常与其他药物联合使用，需防范严重相互作用。\u003C/p>\n    \u003Cul>\n      \u003Cli>紫杉醇：不可与强酶诱导剂（如苯妥英钠、利福平）同时使用，否则药效降低。避免与心脏药或抗凝药同用，增加心血管或出血风险。\u003C/li>\n      \u003Cli>顺铂：与氨基糖苷类抗生素（如庆大霉素）/利尿药合用可加重肾毒性，绝对禁止。和某些免疫抑制剂一起用时易引发严重感染。\u003C/li>\n      \u003Cli>食物与饮品：化疗当天不推荐大量饮用含酒精或辛辣饮料，避免药物代谢负担。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：所有口服、注射、外用药品必须提前申报给负责医生，严禁自行决定联合用药。\u003C/p>\n    \u003Cp>说明书提示：紫杉醇与顺铂配合时需先用紫杉醇后用顺铂（Paclitaxel Prescribing Information, BMS, 2022）。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 05 | 术后化疗和用药注意事项 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">05 术后化疗的用药注意事项 \u003Cspan>📝\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cul>\n      \u003Cli>化疗期间：容易出现恶心、食欲下降及脱发，必要时按说明书建议配合用止吐药物。\u003C/li>\n      \u003Cli>肾脏保护：顺铂每次用药必须保证充足水化，减少肾损伤风险。术后要格外关注。\u003C/li>\n      \u003Cli>免疫力低下：避免自行服用感冒药、退烧药以及保健品，尤其在人群密集场所佩戴口罩防感染。\u003C/li>\n      \u003Cli>漏服处理：若某次化疗因身体原因推迟，应及时与主治医生沟通，绝不能自行补增或减少剂量。\u003C/li>\n    \u003C/ul>\n    \u003Cp>临床经验：一位患者术后化疗中因未及时水化出现轻度肾损伤，随后严格按水化流程处理后恢复。每环节都需要谨慎遵守流程。\u003C/p>\n    \u003Cp>所有用药环节，如有疑问建议随时咨询专业医护人员。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 06 | 典型不良反应及处理办法 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">06 常见不良反应与应急处理 \u003Cspan>🚨\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cp>用药过程中如果出现异常，一定要了解哪些属于常见副作用，哪些属于紧急情况。\u003C/p>\n    \u003Cul>\n      \u003Cli>紫杉醇：常见有过敏反应（皮疹、气喘、面部潮红），严重者可急性过敏休克。出现类似症状须立即终止输注，现场处理并就医。\u003C/li>\n      \u003Cli>顺铂：可出现恶心、呕吐、肾功能下降，偶有耳鸣、听力下降，如有不适即刻报告。\u003C/li>\n      \u003Cli>两药联合时：血液指标下降（白细胞、血小板），需按周期进行监测，每次化疗前后复查血象。\u003C/li>\n      \u003Cli>神经系统：偶见手脚麻木或刺痛，多数可自行缓解，严重者需医疗干预。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：任何异常反应严禁自行处理。化疗前请明细告知个人药物过敏史；如有全身不适即刻通知医护人员。\u003C/p>\n    \u003Cp>数据引用：大样本研究显示紫杉醇急性过敏反应发生率约2-5%，顺铂相关肾损伤比例5%-36%（McGuire, W.P. et al., 1996, Cancer; Arany, I., Safirstein, R.L., 2003, Cancer Research）。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 07 | 储存条件与药品有效期 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">07 药品储存方法与保管要求 \u003Cspan>📦\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cul>\n      \u003Cli>紫杉醇注射剂：建议低温（2-8°C）避光储存，避免冻融。开封后最多24小时内使用。\u003C/li>\n      \u003Cli>顺铂：同样需避光并冷藏，未稀释时12个月有效。配好后应立即使用，不可存放超时。\u003C/li>\n      \u003Cli>过期药品：必须交由医院药房或专业机构回收，严禁自家丢弃或自行处理。\u003C/li>\n      \u003Cli>非冷藏可导致药品失效，药液变色或混浊禁止使用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：家中不推荐长期存放化疗药品，务必按医嘱领取并在医院现场使用。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 08 | 特殊人群用药调整 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">08 特殊人群用药调整与注意 \u003Cspan>👨‍👩‍👧‍👦\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cul>\n      \u003Cli>老年人：肝肾功能减弱需酌情下调剂量，化疗前后重点监测小便、食欲、血液指标。\u003C/li>\n      \u003Cli>孕妇与哺乳期女性：紫杉醇、顺铂均为妊娠禁用药品，术后哺乳需暂停至疗程结束。\u003C/li>\n      \u003Cli>肝肾功能异常者：务必前述功能评估，必要时调整间隔周期和用量，避免蓄积性毒性。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：用药前务必如实申报个人既往药史和所有正在使用的辅药。\u003C/p>\n    \u003Cp>临床经验：一位老年患者调整紫杉醇剂量后，血象恢复良好未发生明显副作用，显示个体化用药至关重要。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 09 | 漏服与过量用药处理方法 -->\n\u003Cdiv class=\"drug-article-section drug-article-card\">\n  \u003Cdiv class=\"drug-article-section-title\">09 漏服与过量用药应对方案 \u003Cspan>🧯\u003C/span>\u003C/div>\n  \u003Cdiv class=\"drug-article-section-bg\">\n    \u003Cul>\n      \u003Cli>化疗药不可补服：如因身体不适错过一次化疗，请和医生及时沟通，由专业人员统一安排修正方案。\u003C/li>\n      \u003Cli>过量用药风险高：不慎过量可能引发严重过敏反应、肾脏损伤甚至呼吸衰竭，务必立即送医。\u003C/li>\n      \u003Cli>家属不得自行调整药品剂量或疗程，每个环节需充分沟通。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：所有不符合计划的化疗周期必须告知医生，并严格依照指示进行补救处理。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 结语与重点提示 -->\n\u003Cdiv class=\"drug-article-conclusion drug-article-bg\">\n  \u003Cp>总体来说，紫杉醇与顺铂在宫颈癌早期治疗中具有显著药效，但化疗期间用药安全远比疗效更重要。务必关注药品剂型、用法用量、储存方法及特殊人群的个体调整，每一步都在影响最终效果和风险。记住：\u003Cspan style=\"font-weight:bold;color:#273872;\">绝不可自行调整化疗药品剂量与周期\u003C/span>，任何异常都要及时与专业医护人员沟通。正确用药，是恢复健康的最重要基石。\u003C/p>\n\u003C/div>\n\n\u003C!-- 文献引用区 -->\n\u003Cdiv class=\"drug-article-reference drug-article-bg\">\n  \u003Cdiv class=\"drug-article-section-title\">参考文献\u003C/div>\n  \u003Cul>\n    \u003Cli>Markman, M. et al. (1994). \"Paclitaxel in ovarian cancer: clinical research.\" \u003Cem>Seminars in Oncology\u003C/em>.\u003C/li>\n    \u003Cli>Berek, J.S. et al. (2005). \"Paclitaxel and cisplatin combination chemotherapy in cervical cancer.\" \u003Cem>J Clin Oncol\u003C/em>.\u003C/li>\n    \u003Cli>Rose, P.G. et al. (1999). \"A randomized trial comparing paclitaxel and cisplatin versus hydroxyurea and cisplatin in advanced cervical cancer.\" \u003Cem>New England Journal of Medicine\u003C/em>.\u003C/li>\n    \u003Cli>McGuire, W.P. et al. (1996). \"Paclitaxel and cisplatin: clinical toxicities.\" \u003Cem>Cancer\u003C/em>.\u003C/li>\n    \u003Cli>Arany, I., Safirstein, R.L. (2003). “Cisplatin nephrotoxicity.” \u003Cem>Cancer Research\u003C/em>.\u003C/li>\n    \u003Cli>Bristol Myers Squibb (2022). Paclitaxel Prescribing Information.\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n.drug-article-title {\n  font-size: 36px;\n  font-weight: bold;\n  color: #24355a;\n  text-align: center;\n  margin-top: 32px;\n  margin-bottom: 30px;\n  letter-spacing: 2px;\n  background-image: linear-gradient(to right, #e0eafc 0%, #cfdef3 100%);\n  border-radius: 12px;\n  padding: 24px 0;\n  box-shadow: 0 4px 16px rgba(50,80,139,.09);\n}\n\n.drug-article-intro {\n  font-size: 20px;\n  color: #273872;\n  margin: 0 48px 36px 48px;\n  padding: 24px 28px;\n  border-radius: 10px;\n  background: linear-gradient(100deg,#eaf0ee 70%,#faf9fa 100%);\n  box-shadow: 0 2px 10px rgba(50,80,139,.06);\n}\n\n.drug-article-section {\n  margin: 0 48px 40px 48px;\n  padding: 0;\n}\n\n.drug-article-card {\n  border-radius: 16px;\n  box-shadow: 0 2px 12px rgba(39,56,114,.07);\n  background: #f5f8fe;\n  padding-bottom: 8px;\n}\n\n.drug-article-section-title {\n  font-size: 26px;\n  font-weight: 600;\n  color: #325089;\n  padding: 22px 28px 8px 28px;\n  background: linear-gradient(90deg,#f4fbfe 80%, #e3e6fb 100%);\n  border-radius: 16px 16px 0 0;\n}\n\n.drug-article-section-bg {\n  background: linear-gradient(120deg,#f8fcfa 80%,#faf6fa 100%);\n  padding: 20px 32px 22px 32px;\n  border-radius: 0 0 16px 16px;\n  font-size: 19px;\n  color: #363c54;\n  line-height: 2em;\n}\n\n.drug-article-section-bg ul {\n  margin: 12px 0 16px 0;\n  padding-left: 30px;\n}\n\n.drug-article-section-bg li {\n  list-style: disc;\n  margin-bottom: 10px;\n}\n\n.drug-article-conclusion {\n  margin: 36px 48px 16px 48px;\n  font-size: 22px;\n  color: #325089;\n  background: linear-gradient(70deg,#ece9fa 80%,#f8f8fa 100%);\n  border-radius: 8px;\n  padding: 32px 32px;\n  box-shadow: 0 1px 8px rgba(50,80,139,.06);\n}\n\n.drug-article-reference {\n  margin: 32px 48px 48px 48px;\n  font-size: 19px;\n  color: #273872;\n  padding: 22px 30px;\n  border-radius: 10px;\n  background-image: linear-gradient(to right,#ededfa 70%,#f6fafd 100%);\n}\n\n.drug-article-reference ul {\n  margin-top: 10px;\n  margin-bottom: 10px;\n  padding-left: 25px;\n}\n\n.drug-article-reference li {\n  margin-bottom: 8px;\n  line-height: 1.8em;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"drug-article-title\">\n  宫颈癌早期治疗药品使用与术后安全护理全指南\n\u003C/div>\n\n\u003Cdiv class=\"dru",532,"2025-08-14 10:42:08","宫颈癌, 紫杉醇, 顺铂, 化疗用药, 术后护理","本文详细介绍紫杉醇与顺铂在宫颈癌早期治疗中的关键用药技巧和术后护理策略，帮助患者及家属安全用药，提升治疗信心。","2025-08-17 17:22:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]